MAPT and Parkinson disease: However, unlike aberrant copy numbers of APP and SNCA, which have been clearly identified in hereditary AD and PD pedigrees, respectively, evidence for a relationship between MAPT gene dosage and either PD or tauopathies remains primarily circumstantial.